A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
NCT ID: NCT05601882
Last Updated: 2025-02-14
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
920 participants
INTERVENTIONAL
2022-11-28
2024-08-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Upadacitinib and dupilumab are approved drugs for the treatment of moderate to severe atopic dermatitis (AD). The study is comprised of a 35-day Screening Period, a 16-week treatment Period 1 and a 16-week treatment Period 2. Participants are randomly assigned to 1 of 2 groups called treatment arms to receive upadacitinib Dose A or dupilumab in Period 1. There is a 30-day or 12-week follow-up visit for those on upadacitinib or dupilumab respectively, who will not enter Period 2. In Period 2, participants will receive upadacitinib Dose A or Dose B for 16 weeks, followed by a 30-day follow-up visit. Approximately 880 adolescent and adult participants ages 12 to 64 with moderate to severe AD who are candidates for systemic therapy will be enrolled at up to 330 sites worldwide.
There may be higher treatment burden for participants in this trial compared to their standard of care . Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
NCT03569293
A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis
NCT03738397
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
NCT06389136
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
NCT06461897
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
NCT03568318
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dupilumab (Period 1)
Adult participants received a loading dose of 600 mg dupilumab by subcutaneous (SC) injection at the Baseline visit followed by 300 mg dupilumab SC every other week (EOW) until Week 16.
Adolescents (12 to 17 years of age and weighing at least 40 kg) received treatment according to their body weight. Participants weighing 40 to \< 60 kg received a loading dose of 400 mg dupilumab SC at the Baseline visit followed by 200 mg SC EOW until Week 16. Those weighing 60 kg or more received a loading dose of 600 mg dupilumab SC at the Baseline visit followed by 300 mg dupilumab SC EOW until Week 16.
Dupilumab
Dupilumab is administered as a subcutaneous (SC) injection.
Upadacitinib (Period 1)
Participants received 15 mg upadacitinib orally once a day (QD) up to Week 16. Starting at Week 4, participants had their dose increased to 30 mg QD if they had a \< 50% reduction from Baseline in Eczema Area and Severity Index (EASI 50) response or a \< 4-point improvement from Baseline in Worst Pruritus Numerical Rating Scale (WP-NRS; weekly average). Starting at Week 8, participants had their dose increased to 30 mg QD if they had a \< EASI 75 response.
Upadacitinib
Extended-release tablet
Dupilumab -> Upadacitinib (Period 2)
At Week 16, participants receiving dupilumab as per its label in Period 1 were reassigned based on their Eczema Area and Severity Index (EASI) response. Those with \< EASI 75 were offered the option to receive oral doses of upadacitinib 15 mg QD in Period 2 up to Week 32. Those with ≥ EASI 75 completed the end of study procedures. Starting at Week 20, participants with \< EASI 75 or a \< 4-point improvement from Baseline in Worst Pruritus Numerical Rating Scale (WP-NRS; weekly average) had their dose increased to 30 mg QD up to Week 32.
Upadacitinib
Extended-release tablet
Upadacitinib -> Upadacitinib 30 mg (Period 2)
At Week 16, participants receiving upadacitinib in Period 1 were reassigned based on their Eczema Area and Severity Index (EASI) response. Those with \< EASI 75 were allocated or continued to receive upadacitinib 30 mg QD in Period 2. Those with ≥ EASI 75 completed the end of study procedures.
Upadacitinib
Extended-release tablet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dupilumab
Dupilumab is administered as a subcutaneous (SC) injection.
Upadacitinib
Extended-release tablet
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Eczema area and severity index (EASI) score ≥ 16;validated Investigator´s Global Assessment for AD (vIGA-AD) score ≥ 3 and ≥ 10% Body Surface Area Involvement of Atopic Dermatitis (BSA of AD) involvement at the Baseline Visit.
* Baseline weekly average of daily Worst Pruritus Numerical Rating Scale (WP-NRS) ≥ 4.
* Documented history of inadequate response to previous systemic treatment defined as documented history of previous inadequate response to at least one prior systemic treatment for AD OR for whom other systemic treatments are otherwise medically inadvisable.
Exclusion Criteria
* History of an organ transplant which requires continued immunosuppression.
12 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AbbVie
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ABBVIE INC.
Role: STUDY_DIRECTOR
AbbVie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical Dermatology Specialists /ID# 250212
Phoenix, Arizona, United States
Alliance Dermatology and Mohs Center /ID# 249671
Phoenix, Arizona, United States
Clinical Trials Institute - Northwest Arkansas /ID# 249838
Fayetteville, Arkansas, United States
Arkansas Research Trials /ID# 250722
North Little Rock, Arkansas, United States
Joseph Raoof Md,Inc /Id# 250211
Encino, California, United States
First OC Dermatology /ID# 250686
Fountain Valley, California, United States
Antelope Valley Clinical Trials /ID# 249946
Lancaster, California, United States
Dermatology Research Associates /ID# 249829
Los Angeles, California, United States
University of California Davis Health /ID# 250044
Sacramento, California, United States
Clinical Trials Research Institute /ID# 250213
Thousand Oaks, California, United States
Western States Clinical Res /ID# 250274
Wheat Ridge, Colorado, United States
UConn Health /ID# 253807
Farmington, Connecticut, United States
Yale Center for Clinical Investigation /ID# 254791
New Haven, Connecticut, United States
Clearlyderm Dermatology /ID# 250457
Boca Raton, Florida, United States
Skin Care Research Boca Raton /ID# 250458
Boca Raton, Florida, United States
Olympian Clinical Research /ID# 250453
Clearwater, Florida, United States
Skin Care Research - Hollywood /ID# 250459
Hollywood, Florida, United States
Solutions Through Adv Rch /ID# 250455
Jacksonville, Florida, United States
GSI Clinical Research, LLC /ID# 250768
Margate, Florida, United States
D&H National Research Centers /ID# 250734
Miami, Florida, United States
Florida International Rsrch cr /ID# 249667
Miami, Florida, United States
Wellness Clinical Research - Miami Lakes /ID# 250236
Miami Lakes, Florida, United States
Tory P Sullivan, MD PA /ID# 251136
North Miami Beach, Florida, United States
Precision Clinical Research /ID# 250990
Sunrise, Florida, United States
Advanced Clinical Research Institute /ID# 250460
Tampa, Florida, United States
Metabolic Research Inst /ID# 250046
West Palm Beach, Florida, United States
Treasure Valley Medical Research /ID# 250727
Boise, Idaho, United States
Dawes Fretzin, LLC /ID# 250276
Indianapolis, Indiana, United States
Randall Dermatology of West Lafayette /ID# 250234
West Lafayette, Indiana, United States
Beth Israel Deaconess Medical Center /ID# 251212
Boston, Massachusetts, United States
Beacon Clinical Research, LLC /ID# 251412
Quincy, Massachusetts, United States
Clarkston Dermatology /ID# 250225
Clarkston, Michigan, United States
Henry Ford Medical Center - New Center One /ID# 250228
Detroit, Michigan, United States
Cleaver Dermatology /ID# 250725
Kirksville, Missouri, United States
MediSearch Clinical Trials /ID# 250272
Saint Joseph, Missouri, United States
Duplicate_Allergy, Asthma & Immunology Associates, PC /ID# 250616
Lincoln, Nebraska, United States
Physician Research Collaboration, LLC /ID# 251099
Lincoln, Nebraska, United States
Montefiore Medical Center - Moses Campus /ID# 251214
The Bronx, New York, United States
Derm of Greater Columbus /ID# 250049
Bexley, Ohio, United States
Univ Hosp Cleveland /ID# 250699
Cleveland, Ohio, United States
Wright State Physicians - Fairborn /ID# 254167
Fairborn, Ohio, United States
Vital Prospects Clinical Research Institute, PC /ID# 249840
Tulsa, Oklahoma, United States
Oregon Dermatology and Research Center /ID# 250726
Portland, Oregon, United States
Oregon Medical Research Center /ID# 249666
Portland, Oregon, United States
Oregon Medical Research Center /ID# 250712
Portland, Oregon, United States
University of Pittsburgh MC /ID# 251208
Pittsburgh, Pennsylvania, United States
Duplicate_Medical University of South Carolina /ID# 251218
Charleston, South Carolina, United States
Health Concepts /ID# 250988
Rapid City, South Dakota, United States
International Clinical Research - Tennessee LLC /ID# 250724
Murfreesboro, Tennessee, United States
Arlington Research Center, Inc /ID# 250468
Arlington, Texas, United States
Orion Clinical Research /ID# 250473
Austin, Texas, United States
Bellaire Dermatology Associates /ID# 250739
Bellaire, Texas, United States
Modern Research Associates, PLLC /ID# 250688
Dallas, Texas, United States
Center for Clinical Studies - Houston - Northwest Freeway /ID# 250039
Houston, Texas, United States
Texas Dermatology and Laser Specialists /ID# 250367
San Antonio, Texas, United States
University of Utah /ID# 250042
Murray, Utah, United States
University of Virginia - Dermatology /ID# 254166
Charlottesville, Virginia, United States
Virginia Clinical Research, Inc. /ID# 249908
Norfolk, Virginia, United States
Premier Specialist /ID# 250572
Kogarah, New South Wales, Australia
Veracity Clinical Research /ID# 249943
Woolloongabba, Queensland, Australia
Skin Health Institute Inc /ID# 249938
Carlton, Victoria, Australia
Sinclair Dermatology - Melbourne /ID# 249937
East Melbourne, Victoria, Australia
Fremantle Dermatology /ID# 249941
Fremantle, Western Australia, Australia
Cliniques Universitaires UCL Saint-Luc /ID# 251403
Woluwe-Saint-Lambert, Brussels Capital, Belgium
Grand Hopital de Charleroi /ID# 251401
Charleroi, Hainaut, Belgium
Universitair Ziekenhuis Leuven /ID# 251399
Leuven, Vlaams-Brabant, Belgium
CHU de Liege /ID# 251400
Liège, , Belgium
UMHAT Dr Georgi Stranski EAD /ID# 251268
Pleven, Smolyan, Bulgaria
Diagnostic Consultative Center Aleksandrovska /ID# 251137
Sofiya, Sofia, Bulgaria
DCC Pulmed AD /ID# 251271
Plovdiv, , Bulgaria
Ambulatory for Specialized Medical Care for skin and venereal diseases /ID# 251272
Sofia, , Bulgaria
Diagnostic consultative center Focus-5 /ID# 251269
Sofia, , Bulgaria
Medical Center Euroderma /ID# 251267
Sofia, , Bulgaria
Medical center EuroHealth /ID# 251270
Sofia, , Bulgaria
Military Medical Academy Multiprofile Hospital /ID# 251187
Sofia, , Bulgaria
MC Zara-Med EOOD /ID# 251135
Stara Zagora, , Bulgaria
Dermatology Research Institute - Blackfoot Trail /ID# 251642
Calgary, Alberta, Canada
Beacon Dermatology Inc /ID# 250336
Calgary, Alberta, Canada
Alberta DermaSurgery Centre /ID# 250217
Edmonton, Alberta, Canada
Dr. Chih-ho Hong Medical Inc. /ID# 251643
Surrey, British Columbia, Canada
Enverus Medical Research /ID# 251645
Surrey, British Columbia, Canada
Wiseman Dermatology Research /ID# 250219
Winnipeg, Manitoba, Canada
Brunswick Dermatology Center /ID# 250220
Fredericton, New Brunswick, Canada
LEADER Research /ID# 251647
Hamilton, Ontario, Canada
DermEffects /ID# 250223
London, Ontario, Canada
Lynde Institute for Dermatology /ID# 251854
Markham, Ontario, Canada
DermEdge Research Inc. /ID# 250216
Mississauga, Ontario, Canada
SKiN Centre for Dermatology /ID# 251853
Peterborough, Ontario, Canada
Toronto Dermatology Centre /ID# 252098
Toronto, Ontario, Canada
Research Toronto /ID# 250222
Toronto, Ontario, Canada
Private Practice - Dr. Kim Papp Clinical Research /ID# 251644
Waterloo, Ontario, Canada
Centre de Recherche dermatologique du Quebec Metropolitain /ID# 250427
Québec, Quebec, Canada
The First Affiliated Hospital Of Fujian Medical University /ID# 249674
Fuzhou, Fujian, China
Dermatology Hospital of Southern Medical University /ID# 250121
Guangzhou, Guangdong, China
Guangzhou First People's Hospital /ID# 249695
Guangzhou, Guangdong, China
The Second Affiliated Hospital of Guangzhou Medical University /ID# 249694
Guangzhou, Guangdong, China
The University of Hong Kong- Shenzhen Hospital /ID# 249436
Shenzhen, Guangdong, China
The Second Xiangya Hospital of Central South University /ID# 249657
Changsha, Guizhou, China
Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 251485
Wuhan, Hubei, China
The First Hospital of China Medical University /ID# 249638
Shenyang, Liaoning, China
Huashan Hospital, Fudan University /ID# 250025
Shanghai, Shanghai Municipality, China
Shanghai Skin Disease Hospital /ID# 249392
Shanghai, Shanghai Municipality, China
Tianjin Medical University General Hospital /ID# 250246
Tianjin, Tianjin Municipality, China
Hangzhou First People's Hospital /ID# 249437
Hangzhou, Zhejiang, China
The second affiliated hospital of Zhejiang University school of medicine /ID# 249655
Hangzhou, Zhejiang, China
Zhejiang Provincial People's Hospital /ID# 249653
Hangzhou, Zhejiang, China
Poliklinika Solmed /ID# 252138
Grad Zagreb, City of Zagreb, Croatia
DermaPlus - Poliklinika za dermatologiju i venerologiju /ID# 249591
Zagreb, City of Zagreb, Croatia
Djecja bolnica Srebrnjak /ID# 249594
Zagreb, City of Zagreb, Croatia
Klinicki bolnicki centar Zagreb /ID# 249596
Zagreb, City of Zagreb, Croatia
Klinika za dječje bolesti Zagreb /ID# 249590
Zagreb, City of Zagreb, Croatia
Klinicki bolnicki centar Rijeka /ID# 249593
Rijeka, Primorje-Gorski Kotar County, Croatia
Klinicki Bolnicki Centar (KBC) Split /ID# 249879
Split, Split-Dalmatia County, Croatia
Bispebjerg and Frederiksberg Hospital /ID# 248902
Copenhagen NV, Capital Region, Denmark
Herlev and Gentofte Hospital /ID# 248900
Hellerup, Capital Region, Denmark
Aarhus Universitetshospital - Skejby /ID# 248899
Aarhus, Central Jutland, Denmark
Roskilde Sygehus /ID# 248901
Roskilde, Region Sjælland, Denmark
Hopital Saint Joseph /ID# 251053
Marseille, Bouches-du-Rhone, France
CHU de Nantes, Hotel Dieu -HME /ID# 251347
Nantes, Pays de la Loire Region, France
HCL - Hopital Lyon Sud /ID# 251343
Pierre-Bénite, Rhone, France
Hôpital Saint-Louis /ID# 251052
Paris, , France
Hôpital Charles-Nicolle /ID# 251055
Rouen, , France
CHU Toulouse - Hopital Larrey /ID# 251344
Toulouse, , France
Universitaetsklinikum Freiburg /ID# 249555
Freiburg im Breisgau, Baden-Wurttemberg, Germany
Universitaetsklinik Heidelberg /ID# 251458
Heidelberg, Baden-Wurttemberg, Germany
Universitaetsklinikum Tuebingen /ID# 249552
Tübingen, Baden-Wurttemberg, Germany
Dermatologische Gemeinschaftspraxis Mahlow /ID# 250306
Blankenfelde-Mahlow, Brandenburg, Germany
Klinikum Darmstadt /ID# 251391
Darmstadt, Hesse, Germany
Universitaetsklinikum Frankfurt /ID# 249544
Frankfurt am Main, Hesse, Germany
Studienzentrum an der Hase GbR Dr. Weyergraf/Dr. Frick/Thomas Heiber /ID# 251392
Bramsche, Lower Saxony, Germany
Universitaetsklinikum Bonn /ID# 250307
Bonn, North Rhine-Westphalia, Germany
Universitaetsklinikum Muenster /ID# 249404
Münster, North Rhine-Westphalia, Germany
Universitaetsmedizin Mainz /ID# 249549
Mainz, Rhineland-Palatinate, Germany
Fachklinik Bad Bentheim /ID# 249545
Bad Bentheim, Saarland, Germany
Universitaetsklinikum Leipzig /ID# 249562
Leipzig, Saxony, Germany
Universitaetsklinikum Schleswig-Holstein Campus Luebeck /ID# 249560
Lübeck, Schleswig-Holstein, Germany
Hautarztpraxis Dr. Niesmann und Dr. Othlinghaus /ID# 251566
Bochum, , Germany
Universitaetsklinikum Carl Gustav Carus an der TU Dresden /ID# 251844
Dresden, , Germany
Derma Study Center Friedrichshafen GmbH /ID# 251460
Friedrichshafen, , Germany
Universitaetsklinikum Hamburg-Eppendorf /ID# 249547
Hamburg, , Germany
Dermatologikum Hamburg /ID# 251390
Hamburg, , Germany
Klinikum rechts der Isar /ID# 249548
Munich, , Germany
401 GSNA - 401 Army General Hospital /ID# 251843
Athens, Attica, Greece
General Hospital Andreas Syggros /ID# 251842
Athens, Attica, Greece
Papageorgiou General Hospital /ID# 251840
Thessaloniki, Evrytania, Greece
Bacs-Kiskun Varmegyei Oktatokorhaz /ID# 249850
Kecskemét, Bács-Kiskun county, Hungary
Debreceni Egyetem-Klinikai Kozpont /ID# 249849
Debrecen, Hajdú-Bihar, Hungary
Gyongyosi Bugat Pal Korhaz /ID# 251367
Gyöngyös, Heves County, Hungary
Pecsi Tudomanyegyetem Klinikai Kozpont /ID# 250419
Pecs, Nógrád megye, Hungary
Somogy Varmegyei Kaposi Mor Oktato Korhaz /ID# 249848
Kaposvár, Somogy County, Hungary
Clinexpert Kft /ID# 249822
Budapest, , Hungary
Semmelweis Egyetem /ID# 251368
Budapest, , Hungary
UNO Medical Trials /ID# 249820
Budapest, , Hungary
DERMA-B Egeszsegugyi es Szolgaltato - Debrecen - Gyepusor Utca /ID# 249819
Debrecen, , Hungary
Szegedi Tudományegyetem /ID# 249818
Szeged, , Hungary
Allergo-Derm Bakos Kft. /ID# 249821
Szolnok, , Hungary
Hadassah Medical Center-Hebrew University /ID# 251576
Jerusalem, Jerusalem, Israel
Rabin Medical Center /ID# 251578
Haifa, , Israel
CAST - Center for Advanced Studies and Technology /ID# 251495
Chieti, L Aquila, Italy
Presidio Ospedaliero San Salvatore /ID# 250127
L’Aquila, L Aquila, Italy
IRCCS Istituto Clinico Humanitas /ID# 251493
Rozzano, Milano, Italy
Azienda Ospedaliera Universitaria Policlinico Tor Vergata /ID# 250125
Rome, Roma, Italy
IRCCS Istituti Fisioterapici Ospitalieri-Istituto Dermatologico San Gallicano /ID# 250558
Rome, Roma, Italy
Policlinico Agostino Gemelli /ID# 251494
Rome, Roma, Italy
ASST degli Spedali Civili di Brescia /ID# 250129
Brescia, , Italy
Ospedale Piero Palagi /ID# 250206
Florence, , Italy
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico /ID# 250123
Milan, , Italy
Azienda Ospedaliero-Universitaria di Modena /ID# 250128
Modena, , Italy
Azienda Ospedaliera di Perugia - Ospedale S. Maria della Misericordia /ID# 251572
Perugia, , Italy
Azienda Ospedaliero Universitaria Pisana /ID# 250124
Pisa, , Italy
Medical Corporation Kojinkai Sapporo Skin Clinic /ID# 252549
Sapporo, Hokkaido, Japan
Medical corporation Kojunkai Kosugi Dermatology Clinic /ID# 252554
Kawasaki-shi, Kanagawa, Japan
National Hospital Organization Sagamihara National Hospital /ID# 254518
Sagamihara-shi, Kanagawa, Japan
Queen's Square Medical Center, Dermatology and Allergology /ID# 252551
Yokohama, Kanagawa, Japan
Osaka Habikino Medical Center /ID# 252550
Habikino-shi, Osaka, Japan
Dermatology and Ophthalmology Kume Clinic /ID# 254570
Sakai-shi, Osaka, Japan
Naoko Dermatology Clinic /ID# 254571
Setagaya-ku, Tokyo, Japan
Centro de Dermatologia de Monterrey /ID# 249126
Monterrey, Estado de Baja California, Mexico
Eukarya PharmaSite, SC /ID# 249702
Monterrey, Nuevo León, Mexico
Cryptex Investigacion Clinica S.A de C.V /ID# 249994
Mexico City, , Mexico
Clinical Research Institute SC /ID# 249647
Tlalnepantla, , Mexico
Arké Estudios Clinicos Veracruz /ID# 250147
Veracruz, , Mexico
Bravis Ziekenhuis /ID# 251395
Bergen op Zoom, North Brabant, Netherlands
Amsterdam UMC, locatie AMC /ID# 251397
Amsterdam, North Holland, Netherlands
Solumed Centrum Medyczne /ID# 249641
Poznan, Greater Poland Voivodeship, Poland
MICS Centrum Medyczne Torun /ID# 251433
Torun, Kuyavian-Pomeranian Voivodeship, Poland
Lidia Rajzer - Specjalistyczny Gabinet Dermatologiczno-Kosmetyczny /ID# 252082
Krakow, Lesser Poland Voivodeship, Poland
Centrum Nowoczesnych Terapii Dobry Lekarz Sp. z o.o. /ID# 251437
Krakow, Lesser Poland Voivodeship, Poland
Klinika Ambroziak Sp. z o.o. /ID# 249406
Warsaw, Masovian Voivodeship, Poland
Royalderm Agnieszka Nawrocka /ID# 251432
Warsaw, Masovian Voivodeship, Poland
Bodyclinic Sp. z o.o. sp.k. /ID# 249599
Warsaw, Masovian Voivodeship, Poland
Zespol Naukowo-Leczniczy Iwolang Dermatologiczne Centrum Uzdrowiskowe Sp. z o.o /ID# 249598
Iwonicz-Zdrój, Podkarpackie Voivodeship, Poland
INTER CLINIC Piotr Adrian Klimiuk /ID# 251430
Bialystok, Podlaskie Voivodeship, Poland
Centrum Badan Klinicznych PI-House sp. z o.o. /ID# 251431
Gdansk, Pomeranian Voivodeship, Poland
Centrum Kliniczno-Badawcze J.Brzezicki, B. Gornikiewicz-Brzezicka Lekarze Spolka /ID# 251438
Elblag, Warmian-Masurian Voivodeship, Poland
Centrum Medyczne ALL-MED Badania Kliniczne /ID# 249630
Krakow, , Poland
Dermed Centrum Medyczne Sp. z o.o /ID# 251429
Lodz, Łódź Voivodeship, Poland
Centro Hospitalar Do Alto Ave - Hospital Senhora Da Oliveira /ID# 249196
Guimarães, Braga District, Portugal
Hospital CUF Descobertas /ID# 249193
Lisboa, Madeira, Portugal
Centro Hospitalar Universitario do Porto, EPE - Hospital Santo Antonio /ID# 249191
Porto, Madeira, Portugal
Hospital Garcia de Orta /ID# 251455
Almada, Setúbal District, Portugal
2CA-Braga, Hospital de Braga /ID# 250480
Braga, , Portugal
Unidade Local de Saude da Regiao de Leiria, EPE /ID# 249194
Leiria, , Portugal
Centro Hospitalar de Lisboa Central /ID# 249195
Lisbon, , Portugal
Unidade Local de Saúde de Matosinhos, EPE /ID# 249197
Matosinhos Municipality, , Portugal
Centro Hospitalar Universitario de Sao Joao, EPE /ID# 249192
Porto, , Portugal
Dr. Samuel Sanchez PSC /ID# 250389
Caguas, , Puerto Rico
Alma M. Cruz Santana, MD-Private practice /ID# 250393
Carolina, , Puerto Rico
Clinical Research Puerto Rico /ID# 250394
San Juan, , Puerto Rico
GCM Medical Group PSC /ID# 250391
San Juan, , Puerto Rico
Bio Terra Med SRL /ID# 249624
Bucharest, București, Romania
Private Practice - Dr. Orasan Remus /ID# 249625
Cluj-Napoca, Cluj, Romania
Derma therapy spol /ID# 249783
Bratislava, Bratislava Region, Slovakia
Poliklinika Bezrucova (Cliniq s.r.o.) /ID# 249746
Bratislava, , Slovakia
BeneDerma s.r.o. /ID# 251791
Bratislava, , Slovakia
University of Pretoria /ID# 250208
Pretoria, Gauteng, South Africa
About Allergy /ID# 249697
Pretoria, Gauteng, South Africa
Highway Medical Centre /ID# 250103
Durban, KwaZulu-Natal, South Africa
Allergy & Immunology (AIU) /ID# 249619
Cape Town, Western Cape, South Africa
Spoke Research Inc /ID# 250091
CAPE TOWN Milnerton, Western Cape, South Africa
Pusan National University Hospital /ID# 249852
Busan, Busan Gwang Yeogsi, South Korea
Kyungpook National University Hospital /ID# 249855
Junggu, Daegu Gwang Yeogsi, South Korea
Korea University Ansan Hospital /ID# 249814
Ansan-si, Gyeonggido, South Korea
Soon Chun Hyang University Hospital Bucheon /ID# 249812
Bucheon-si, Gyeonggido, South Korea
Chungang University Hospital /ID# 251490
Dongjak-gu, Gyeonggido, South Korea
Ajou University Hospital /ID# 251491
Suwon, Gyeonggido, South Korea
Seoul National University Hospital /ID# 251492
Seoul, Seoul Teugbyeolsi, South Korea
Konkuk University Medical Center /ID# 249811
Seoul, Seoul Teugbyeolsi, South Korea
Hospital Universitario Germans Trias i Pujol /ID# 251523
Badalona, Barcelona, Spain
Hospital Sant Joan de Deu /ID# 249602
Esplugues de Llobregat, Barcelona, Spain
Hospital Universitario Basurto /ID# 249784
Bilbao, Vizcaya, Spain
Hospital General Universitario de Alicante Doctor Balmis /ID# 251517
Alicante, , Spain
Hospital Universitario Virgen de las Nieves /ID# 249785
Granada, , Spain
Hospital Universitario La Paz /ID# 251518
Madrid, , Spain
Hospital Universitario Virgen Macarena /ID# 249603
Seville, , Spain
Hospital Universitario y Politecnico La Fe /ID# 251524
Valencia, , Spain
Skane University hospital /ID# 250332
Malmo, Skåne County, Sweden
Karolinska University Hospital Solna /ID# 250328
Solna, Stockholm County, Sweden
Norrlands University hospital /ID# 250329
Umeå, Västerbotten County, Sweden
Malarsjukhuset /ID# 251908
Eskilstuna, , Sweden
Kantonsspital St. Gallen /ID# 250606
Sankt Gallen, Canton of St. Gallen, Switzerland
Inselspital, Universitaetsspital Bern /ID# 250577
Bern, , Switzerland
Kaohsiung Chang Gung Memorial Hospital /ID# 249260
Kaohsiung City, Kaohsiung, Taiwan
Taichung Veterans General Hospital /ID# 249261
Taichung, Keelung, Taiwan
National Taiwan University Hospital /ID# 249258
Taipei City, Taipei, Taiwan
National Taiwan University Hospital - Hsinchu branch /ID# 249265
Hsinchu, , Taiwan
Taipei Medical University Shuang Ho Hospital /ID# 249256
New Taipei City, , Taiwan
Mackay Memorial Hospital /ID# 249259
Taipei, , Taiwan
Taipei Veterans General Hosp /ID# 249263
Taipei, , Taiwan
Taipei Municipal Wan Fang Hospital /ID# 251500
Taipei, , Taiwan
Linkou Chang Gung Memorial Hospital /ID# 249257
Taoyuan, , Taiwan
Gaziantep Universitesi /ID# 249868
Gaziantep, Adana, Turkey (Türkiye)
Ankara City Hospital /ID# 249870
Ankara, , Turkey (Türkiye)
Akdeniz Universitesi Tip Fakul /ID# 249866
Antalya, , Turkey (Türkiye)
Uludag University Medical Faculty /ID# 249864
Bursa, , Turkey (Türkiye)
Erciyes University Medical Faculty /ID# 249863
Kayseri, , Turkey (Türkiye)
Ondokuz Mayis Universitesi /ID# 249865
Samsun, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
Related info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-002482-15
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
M23-696
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.